全球避孕药市场 – 行业趋势及 2030 年预测

避孕药市场分析及规模

根据世界卫生组织的数据，2019 年全球 19 亿 15-49 岁育龄妇女中，约有 11 亿需要计划生育。避孕服务和计划正逐渐认识到人权的重要性。避孕措施的使用增加降低了性传播感染的风险，并改善了孕产妇和婴儿死亡率等健康相关结果。  

Data Bridge Market Research 分析了 2023-2030 年预测期内避孕药市场的增长率。在上述预测期内，避孕药市场的预期复合年增长率约为 6.51%。2022 年市场价值为 286.5 亿美元，到 2030 年将增长至 474.5 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

避孕药市场范围和细分

Market Definition

Contraception aims to prevent pregnancy as birth control pills or tablets. For the prevention of pregnancy, contraception is used as a consequence of sexual intercourse. The major forms of artificial contraception are contraceptive pills, IUDs, barrier methods, implants and sterilization.  

Global Contraceptives Market Dynamics

Drivers

• Increase R&D Activities

The increased R&D activities cause the market to flourish. Numerous treatment options have been studied and research has been carried out to overcome the burden of unwanted pregnancy. During clinical trials, several new types of contraceptive pills and gels will be introduced that are projected to work around new laws and limitations on current birth control procedures. Eventually, research is ongoing to concentrate on developing a non-hormonal pill which could expand the range of birth control options available to men.

• Rising Awareness by Different Organizations

The WHO has launched an app which outlines its medical guidelines for contraception use. Women will benefit from this digital tool because it is effective, safe, and acceptable contraceptives. WHO published a report in 2017, with a user-friendly checklist that primarily focuses on human rights standards in the provision of contraceptive information and services.

Opportunities

• Increase in Initiatives by Organizations

Numerous initiatives, such as Every Woman Every Child, Millennium Development Goals, the 2030 Sustainable Development Goals (SDGs), and Family Planning 2020 (FP2020), have been launched by governments and other healthcare organizations for family planning is promoting the use and manufacturing of contraceptives. For instance, Family Planning 2020 was the initiative launched in 2012 and ran up to 2020, that offered global partnerships to share knowledge and offer a right-based, person-centered approach to family planning. The initiative was later expanded to 2030 to ensure the accessibility of contraceptives and other family planning resources worldwide.

• Growing Adoption of Oral Contraceptives

Oral contraceptives are highly used after by young people in developing nations. The high number of government sponsored programs and the free provision of contraceptives in rural and urban areas will boost growth in the sale and wide use of these pills in the market. In addition to the growing challenges that are related with teenage pregnancies, growing knowledge of modern contraception and the issue of unplanned pregnancies will continue to further pushthe market for oral pills.

Restraints/Challenges

• Lack of Awareness About Contraception

The lack of understanding while using these long-term contraceptive pills causes apprehension about accepting them. In underdeveloped countries, the social stigma associated with the use of contraception methods and the expensive cost of these methods and pills are responsible for the low uptake and acceptability of these methods.

• Side-Effects of Contraceptives

The adverse side-effects associated with the treatment process hinder the market growth. In rare cases, the side effects are very severe such as heart attacks, blood clots in the legs, and stroke, liver disorders, and gallbladder disease. These side effects that are related with the usage of contraceptives will limit the sales during the forecast period.

This contraceptives market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contraceptives market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Contraceptives Market

COVID-19 has significantly impacted the contraceptives market value. The initiation of novel innovations and technologies during the outbreak become the routine standard of care comprising the use of telemedicine and telehealth in contraception initiation and continuation. Numerous telehealth modalities enable patients to connect using technology to deliver health care. Supporting mobile outreach services to deliver a wide range of contraception products in areas having poor access to healthcare providers has increased the industry value.

Recent Development

• In December 2021, Cooper Surgical, Inc. acquired Generate Life Sciences. This acquisition helps Cooper to improve their reproductive segment. Generate Life Sciences, which is a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage, for a purchase price of around $1.6 billion.

Global Contraceptives Market Scope

The contraceptives market is segmented on the basis of treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Contraceptive Drugs
• Contraceptive Pills
• Patch
• Injectables
• Intra-Uterine Devices
• Copper
• Hormonal
• Pills
• Cervical Caps
• Condoms
• Male
• Female
• Diaphragms
• Injections

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

分销渠道

• 医院药房
• 网上药店
• 零售药店

避孕药市场区域分析/见解

对避孕药市场进行了分析，并根据上述治疗、分销渠道和最终用户提供了市场规模洞察和趋势。

避孕药市场报告涉及的主要国家 有：北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于面临意外怀孕风险的女性（尤其是在美国和加拿大）对避孕药的需求不断增加，北美避孕药市场在整个预测期内一直呈现积极增长。

由于医疗保健支出不断增加且优先考虑女性健康，亚太地区在市场中占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球避孕药市场份额分析

避孕药市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对避孕药市场的关注有关

避孕药市场的主要参与者包括：

• Abbvie, Inc（美国）
• Afaxys, Inc.（美国）
• 默克公司（美国）
• Teva Pharmaceuticals Industries Ltd.（以色列）
• 拜耳公司（德国）
• 辉瑞公司（美国）
• Agile Therapeutics（美国）
• Cupid Ltd.（印度）
• Helm AG（德国）
• Church & Dwight Co., Inc（美国）
• Organon 集团公司（美国）
• 利洁时集团有限公司（英国）
• Veru Inc.（美国）

SKU-56738